Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Procter and Gamble Co | 117 |
| 2 | Bayer AG | 47 |
| 3 | Roche Holding AG | 41 |
| 4 | China Petrochemical Corp | 26 |
| 5 | Air Liquide SA | 10 |
| 6 | Evonik Industries AG | 10 |
| 7 | Novartis AG | 10 |
| 8 | Wilmar International Ltd | 9 |
| 9 | Chinese Academy of Sciences | 7 |
| 10 | SLB NV | 7 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 286 |
| 2 | A61P | Therapeutic activity (drug indications) | 193 |
| 3 | C11D | Detergents, cleaning compositions | 123 |
| 4 | C07D | Heterocyclic compounds | 118 |
| 5 | A61Q | Cosmetics, personal care | 83 |
| 6 | C08F | Polymers from C=C unsaturated bonds | 61 |
| 7 | A01N | Preservation of bodies; biocides; pest repellents | 57 |
| 8 | C08L | Polymer compositions (blends) | 53 |
| 9 | C08K | Polymer compositions (additives) | 46 |
| 10 | C07C | Acyclic and carbocyclic compounds | 43 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| The improvement of Sorbitan Stearate (sorbester p18) fatty acid composition measuring method | 2019 | 6 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 9 |
| 2017 | 5 |
| 2018 | 13 |
| 2019 | 13 |
| 2020 | 6 |
| 2021 | 5 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 3 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Adriana Raffin Pohlmann | Universidade Federal do Rio Grande do Sul | 6 |
| 2 | Sı́lvia Stanisçuaski Guterres | Universidade Federal do Rio Grande do Sul | 6 |
| 3 | Alexander T. Florence | University of London | 6 |
| 4 | Sudaxshina Murdan | University of London | 5 |
| 5 | Krishna Pramanik | National Institute of Technology Rourkela | 4 |
| 6 | Kunal Pal | National Institute of Technology Rourkela | 4 |
| 7 | Ruy Carlos Ruver Beck | Universidade Federal do Rio Grande do Sul | 3 |
| 8 | Ibrahim Elsayed | Gulf Medical University | 3 |
| 9 | Alejandro G. Marangoni | University of Guelph | 3 |
| 10 | Kai Dämmert | Rosalind Franklin University of Medicine and Science | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide | 2005 | 353 | Advancements in Transdermal Drug Delivery |
| Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid | 2011 | 254 | Advancements in Transdermal Drug Delivery |
| Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level box-behnken design | 2007 | 207 | RNA Interference and Gene Delivery |
| Effect of cholesterol and temperature on the elastic properties of niosomal membranes | 2005 | 204 | Lipid Membrane Structure and Behavior |
| Preparation and characterization of novel carbopol based bigels for topical delivery of metronidazole for the treatment of bacterial vaginosis | 2014 | 162 | Polysaccharides Composition and Applications |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of this compound?
Which organization holds the most patents related to this compound?
What are the most common research topics associated with this compound in published literature?
What patent classification codes are most frequently associated with patents containing this compound?
How has patent filing activity for this compound changed in recent years?